Kinzler KW, Vogelstein B: Life (and death) in a malignant tumour. Nature. 1996, 379: 19-20. 10.1038/379019a0.
Article
CAS
PubMed
Google Scholar
Chung DC: The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology. 2000, 119: 854-865. 10.1053/gast.2000.16507.
Article
CAS
PubMed
Google Scholar
Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K, Boland CR: Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res. 2001, 61: 2676-2683.
CAS
PubMed
Google Scholar
Cardoso J, Boer J, Morreau H, Fodde R: Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta. 2007, 1775: 103-137.
CAS
PubMed
Google Scholar
Calvert PM, Frucht H: The genetics of colorectal cancer. Ann Intern Med. 2002, 137: 603-612.
Article
CAS
PubMed
Google Scholar
Tullo A, D'Erchia AM, Honda K, Mitry RR, Kelly MD, Habib NA, Saccone C, Sbisa E: Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters. Clin Cancer Res. 1999, 5: 3523-3528.
CAS
PubMed
Google Scholar
Srivastava S, Verma M, Henson DE: Biomarkers for early detection of colon cancer. Clin Cancer Res. 2001, 7: 1118-1126.
CAS
PubMed
Google Scholar
Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB, Hamilton SR: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med. 2001, 344: 1196-1206. 10.1056/NEJM200104193441603.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grizzle WE, Adam BL, Bigbee WL, Conrads TP, Carroll C, Feng Z, Izbicka E, Jendoubi M, Johnsey D, Kagan J, et al: Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Dis Markers. 2003, 19: 185-195.
Article
CAS
PubMed
Google Scholar
Barrier A, Boelle PY, Roser F, Gregg J, Tse C, Brault D, Lacaine F, Houry S, Huguier M, Franc B, et al: Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol. 2006, 24: 4685-4691. 10.1200/JCO.2005.05.0229.
Article
CAS
PubMed
Google Scholar
Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, McLeod HL, Atkins D: Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol. 2004, 22: 1564-1571. 10.1200/JCO.2004.08.186.
Article
CAS
PubMed
Google Scholar
Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971, 68: 820-823. 10.1073/pnas.68.4.820.
Article
PubMed
PubMed Central
Google Scholar
Knosel T, Schluns K, Stein U, Schwabe H, Schlag PM, Dietel M, Petersen I: Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia. 2004, 6: 23-28.
Article
PubMed
PubMed Central
Google Scholar
Blaker H, Graf M, Rieker RJ, Otto HF: Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases. J Pathol. 1999, 188: 258-262. 10.1002/(SICI)1096-9896(199907)188:3<258::AID-PATH350>3.0.CO;2-9.
Article
CAS
PubMed
Google Scholar
Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA: The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer. 2006, 45: 31-41. 10.1002/gcc.20261.
Article
CAS
PubMed
Google Scholar
Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H, Okumura K: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med. 2001, 7: 94-100. 10.1038/83416.
Article
CAS
PubMed
Google Scholar
Friedman JB, Brunschwig EB, Platzer P, Wilson K, Markowitz SD: C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer. Int J Cancer. 2004, 111: 72-75. 10.1002/ijc.20235.
Article
CAS
PubMed
Google Scholar
Oyama T, Miyoshi Y, Koyama K, Nakagawa H, Yamori T, Ito T, Matsuda H, Arakawa H, Nakamura Y: Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis. Genes Chromosomes Cancer. 2000, 29: 9-15. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#.
Article
CAS
PubMed
Google Scholar
Shin MS, Kim HS, Lee SH, Park WS, Kim SY, Park JY, Lee JH, Lee SK, Lee SN, Jung SS, et al: Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res. 2001, 61: 4942-4946.
CAS
PubMed
Google Scholar
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 1990, 61: 759-767. 10.1016/0092-8674(90)90186-I.
Article
CAS
PubMed
Google Scholar
Ku WH, Liu IL, Yen MS, Chang Chien CC, Yue CT, Ma YY, Chang SF, Ng HT, Wu CW, Shen CY: Genomic deletion and p53 inactivation in cervical carcinoma. Int J Cancer. 1997, 72: 270-276. 10.1002/(SICI)1097-0215(19970717)72:2<270::AID-IJC12>3.0.CO;2-K.
Article
CAS
PubMed
Google Scholar
Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JC: A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res. 1994, 54: 4003-4006.
CAS
PubMed
Google Scholar
Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG: The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 2004, 64: 883-888. 10.1158/0008-5472.CAN-03-1346.
Article
CAS
PubMed
Google Scholar
Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS: Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res. 2001, 7: 1688-1697.
CAS
PubMed
Google Scholar
Dechant MJ, Fellenberg J, Scheuerpflug CG, Ewerbeck V, Debatin KM: Mutation analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines. Int J Cancer. 2004, 109: 661-667. 10.1002/ijc.20008.
Article
CAS
PubMed
Google Scholar
Loughran G, Healy NC, Kiely PA, Huigsloot M, Kedersha NL, O'Connor R: Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth. Mol Biol Cell. 2005, 16: 1811-1822. 10.1091/mbc.E04-12-1052.
Article
CAS
PubMed
PubMed Central
Google Scholar
[http://www.ensemble.org]
Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth. Cell Immunol. 2001, 214: 194-200. 10.1006/cimm.2001.1896.
Article
CAS
PubMed
Google Scholar
Tanaka T, Grusby MJ, Kaisho T: PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol. 2007, 8: 584-591. 10.1038/ni1464.
Article
CAS
PubMed
Google Scholar
Arai T, Akiyama Y, Okabe S, Saito K, Iwai T, Yuasa Y: Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas. Cancer Lett. 1998, 133: 197-204. 10.1016/S0304-3835(98)00230-4.
Article
CAS
PubMed
Google Scholar
Strater J, Hinz U, Walczak H, Mechtersheimer G, Koretz K, Herfarth C, Moller P, Lehnert T: Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res. 2002, 8: 3734-3740.
PubMed
Google Scholar
Ponting CP, Phillips C, Davies KE, Blake DJ: PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays. 1997, 19: 469-479. 10.1002/bies.950190606.
Article
CAS
PubMed
Google Scholar
Bach I: The LIM domain: regulation by association. Mech Dev. 2000, 91: 5-17. 10.1016/S0925-4773(99)00314-7.
Article
CAS
PubMed
Google Scholar
Hamaguchi M, Meth JL, von Klitzing C, Wei W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC, Wigler MH: DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci USA. 2002, 99: 13647-13652. 10.1073/pnas.212516099.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sundararajan R, Chen G, Mukherjee C, White E: Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling. Oncogene. 2005, 24: 4908-4920. 10.1038/sj.onc.1208681.
Article
CAS
PubMed
Google Scholar
Trauernicht AM, Kim SJ, Kim NH, Boyer TG: Modulation of estrogen receptor alpha protein level and survival function by DBC-1. Mol Endocrinol. 2007, 21: 1526-1536. 10.1210/me.2007-0064.
Article
CAS
PubMed
Google Scholar
Siripurapu V, Meth J, Kobayashi N, Hamaguchi M: DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J Mol Biol. 2005, 346: 83-89. 10.1016/j.jmb.2004.11.043.
Article
CAS
PubMed
Google Scholar
Aspenstrom P, Fransson A, Saras J: Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J. 2004, 377: 327-337. 10.1042/BJ20031041.
Article
PubMed
PubMed Central
Google Scholar
Collado D, Yoshihara T, Hamaguchi M: DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation. Biochem Biophys Res Commun. 2007, 360: 600-603. 10.1016/j.bbrc.2007.06.127.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chang AC, Jellinek DA, Reddel RR: Mammalian stanniocalcins and cancer. Endocr Relat Cancer. 2003, 10: 359-373. 10.1677/erc.0.0100359.
Article
CAS
PubMed
Google Scholar
Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ: A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 2002, 62: 4478-4483.
CAS
PubMed
Google Scholar
Rost T, Pyritz V, Rathcke IO, Gorogh T, Dunne AA, Werner JA: Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. Anticancer Res. 2003, 23: 1565-1573.
CAS
PubMed
Google Scholar
Fong SF, Dietzsch E, Fong KS, Hollosi P, Asuncion L, He Q, Parker MI, Csiszar K: Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors. Genes Chromosomes Cancer. 2007, 46: 644-655. 10.1002/gcc.20444.
Article
CAS
PubMed
Google Scholar
Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A, Portillo F: A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. Embo J. 2005, 24: 3446-3458. 10.1038/sj.emboj.7600781.
Article
CAS
PubMed
PubMed Central
Google Scholar
Peinado H, Portillo F, Cano A: Switching on-off Snail: LOXL2 versus GSK3beta. Cell Cycle. 2005, 4: 1749-1752.
Article
CAS
PubMed
Google Scholar
Horii M, Shibata H, Kobayashi R, Katoh K, Yorikawa C, Yasuda J, Maki M: CHMP7, a novel ESCRT-III-related protein, associates with CHMP4b and functions in the endosomal sorting pathway. Biochem J. 2006, 400: 23-32. 10.1042/BJ20060897.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, et al: Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999, 13: 966-977. 10.1101/gad.13.8.966.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abdulkadir SA: Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Ann N Y Acad Sci. 2005, 1059: 33-40. 10.1196/annals.1339.018.
Article
CAS
PubMed
Google Scholar
Mochizuki S, Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98: 621-628. 10.1111/j.1349-7006.2007.00434.x.
Article
CAS
PubMed
Google Scholar
[http://www.ncbi.nlm.nih.gov/geo]
Mueller CG, Rissoan MC, Salinas B, Ait-Yahia S, Ravel O, Bridon JM, Briere F, Lebecque S, Liu YJ: Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells. J Exp Med. 1997, 186: 655-663. 10.1084/jem.186.5.655.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pai SI, Wu GS, Ozoren N, Wu L, Jen J, Sidransky D, El-Deiry WS: Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Cancer Res. 1998, 58: 3513-3518.
CAS
PubMed
Google Scholar
Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, et al: Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res. 1999, 59: 5683-5686.
CAS
PubMed
Google Scholar
Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, et al: Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene. 2001, 20: 399-403. 10.1038/sj.onc.1204103.
Article
CAS
PubMed
Google Scholar
Adams J, Cuthbert-Heavens D, Bass S, Knowles MA: Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity. Cancer Lett. 2005, 220: 137-144. 10.1016/j.canlet.2004.06.052.
Article
CAS
PubMed
Google Scholar
Wang S, El-Deiry WS: Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil. Cancer Res. 2004, 64: 6666-6672. 10.1158/0008-5472.CAN-04-1734.
Article
CAS
PubMed
Google Scholar
Hurst LD, Pal C, Lercher MJ: The evolutionary dynamics of eukaryotic gene order. Nat Rev Genet. 2004, 5: 299-310. 10.1038/nrg1319.
Article
CAS
PubMed
Google Scholar
Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T: Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genet. 2007, 8: 104-115. 10.1038/nrg2041.
Article
CAS
PubMed
Google Scholar
van Noesel MM, van Bezouw S, Voute PA, Herman JG, Pieters R, Versteeg R: Clustering of hypermethlyated genes in neuroblastoma. Genes Chromosomes Cancer. 2003, 38: 226-233. 10.1002/gcc.10278.
Article
CAS
PubMed
Google Scholar
Han H, Russo J, Kohwi Y, Kohwi-Shigematsu T: SATB1 reprogrammed gene expression to promote breast tumour growth and metastasis. Nature. 2008, 452: 187-193. 10.1038/nature06781.
Article
CAS
PubMed
Google Scholar